NCT07276360 2025-12-11
HypoRTCx-UG
Uganda Cancer Institute
Phase 2 Not yet recruiting
Clinical Trials
17 trialsNCT07232654 2025-12-01
Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT00924027 2025-09-05
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT06419673 2024-05-17
Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting
NCT01041027 2023-10-26
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer
Albert Einstein College of Medicine
Phase 2 Terminated
NCT05799469 2023-04-05
Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer
Chongqing University Cancer Hospital
Phase 2 Not yet recruiting
NCT00492778 2023-03-29
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
GOG Foundation
Phase 2 Unknown
NCT05772377 2023-03-16
Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT01399658 2023-03-14
AMIGO
Dana-Farber Cancer Institute
Phase 2 Completed
NCT05105672 2021-12-28
A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer
The Affiliated Hospital of Xuzhou Medical University
Phase 2 Unknown
NCT03469531 2018-08-13
Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Zhujiang Hospital
Phase 2 Unknown
NCT02501278 2016-05-13
A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Withdrawn
NCT02705612 2016-03-10
Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer
Air Force Military Medical University, China
Phase 2 Unknown
NCT00462397 2013-08-26
Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00008112 2013-08-07
Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00278304 2013-06-20
Radiation Therapy in Treating Patients With Cervical Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01158248 2010-07-09
Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer
National Cancer Institute (NCI)
Phase 2 Unknown